Name: Ipamorelin / CJC-1295 mix 5mg+5mg
SKU: 439
Availability: InStock

Ipamorelin / CJC-1295 mix 5mg+5mg

49,99 €

36 Items sold in last 3 minutes

15 People watching this product now!

Research-grade Ipamorelin / CJC-1295 Blend 10 mg as a lyophilized powder in a glass vial. This blend contains 5 mg of Ipamorelinand 5 mg of CJC-1295 without DAC (Mod GRF 1-29), combined for synergistic research into growth hormone secretion.

For diluting lyophilized peptide powders, use a sterile, suitable solvent such as bacteriostatic water (BAC), which helps maintain stability and reduce contamination risk. For convenient dosing and safe handling,
see Bacteriostatic water – 10 ml.

Parameter	Value
Form	Lyophilized peptide powder
Content	5 mg Ipamorelin & 5 mg CJC-1295 (no DAC) per vial
Packaging	Glass vial with sterile closure
Storage	Store lyophilized at 2–8 °C (desiccated, protect from light)
Molecular formula	Mixture
Molecular weight	Mixture
Sequences	Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH2 CJC-1295 (no DAC): Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
CAS number	170851-70-4 (Ipamorelin) 863288-34-0 (CJC-1295 no DAC)

Ipamorelin / CJC-1295

What is the Ipamorelin / CJC-1295 Blend?

This research blend combines two growth hormone (GH) secretagogues that act on different receptors. Ipamorelin is a selective agonist of the ghrelin/growth hormone secretagogue receptor (GHS-R). CJC-1295 (no DAC), also known as Modified GRF (1-29), is an analog of Growth Hormone Releasing Hormone (GHRH). They are combined to study the synergistic effect of activating both pathways simultaneously.

In laboratory studies, this blend is associated with research into: